Raymond James Maintains Outperform on Insulet, Lowers Price Target to $213
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jayson Bedford has maintained an Outperform rating on Insulet (NASDAQ:PODD) but has lowered the price target from $218 to $213.

May 10, 2024 | 5:04 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Raymond James has maintained its Outperform rating on Insulet but reduced the price target from $218 to $213, indicating a positive outlook with a slightly reduced valuation expectation.
The maintenance of an Outperform rating by a reputable analyst like Raymond James suggests a continued positive outlook on Insulet's performance. However, the reduction in the price target, albeit slight, could indicate a minor adjustment in valuation expectations based on recent data or market conditions. This adjustment is likely to have a neutral to slightly positive impact on the stock in the short term, as the endorsement of the stock's potential remains strong despite the slight decrease in the price target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100